Skip to content

Effects of Pregnancy for Cystic Fibrosis Patients

Search Clinical Trials

Trial Objectives


A national research study called MAYFLOWERS wants to understand the changes of lung function in pregnant women with cystic fibrosis (CF) during pregnancy and 2 years after delivery. It also looks at the health of their babies. Additionally, if women are taking any Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator, including TRIKAFTA®, the study will look at the effect of modulator on the health of mother and baby.

Who Can Participate


Pregnant women with cystic fibrosis.

Age: 16+ Gender Any

Estimated Time Commitment


7 to 9 clinic visits

Time Commitment Details


Up to three visits during pregnancy and up to six visits over the two years after delivery.

Payment & Reimbursement


Payment Provided

Travel Reimbursement Available

Trial Contact


For more information, contact:

Salma Moreno
303-270-2681

Request More Information

Trial Location


National Jewish Main Campus, Denver, CO

Trial Sponsors


TDN

Principal Investigators

Jennifer L. Taylor-Cousar

Jennifer L. Taylor-Cousar, MD, MSCS

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required